Overture Life Receives CE Mark Approval to Commercialize Fertility Automation in Europe

Contributed by: Business Wire

Logo

Tags

Research

Hardware

Family

Robotics

Consumer

Technology

Medical Devices

Health Technology

Parenting

Science

Baby/Maternity

Biotechnology

Health

Overture Life Receives CE Mark Approval in Europe

More Like This

Overture Life Launches European Preorder Waitlist for DaVitri, the World’s First Microfluidics-Based Automated Vitrification Platform

BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System

GlobeNewswire associated0

Conceivable Life Sciences Secures $50 Million Series A

PR Newswire associated0

Alife Health Receives CE Mark Under European Medical Device Regulation for Embryo Predict™, Its AI-Powered Embryo Selection Tool

PR Newswire associated0

TMRW Life Sciences Expands Globally Entering UK Fertility Market

PR Newswire associated0

FutureLife becomes first European fertility network to adopt an end-to-end AI fertility platform, in partnership with Alife Health

PR Newswire associated0

AVENUES: FROM FERTILISATION FAILURE TO FATHERHOOD, GLOBAL FIRST ACHIEVED BY AI-POWERED FERTILITY CLINIC

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers